— Know what they know.
Not Investment Advice

EDXC OTC

Endexx Corporation
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -87.5% 1Y: -95.8% 3Y: -99.8% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 52 · $57185 mcap · 479M float · 0.150% daily turnover · Short 71% of daily vol

Cash Flow Trends

Operating Cash Flow
-$452K +72.2% ▲
Capital Expenditures
$0 +100.0% ▲
Free Cash Flow
-$452K +72.2% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$132 +100.0% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$8M-$7M-$4M-$6M-$3M
Depreciation & Amort.$15K$20K$21K$10K$0
Stock-Based Comp.$1M$721K$456K$0$0
Change in Working Capital-$246K$1M$2M$3M$2M
Other Non-Cash Items$3M$1M-$295K$2M$1M
Operating Cash Flow-$2M-$4M-$1M-$2M-$452K
— Investing Activities —
Capital Expenditures-$100K$0$0-$3$0
Acquisitions (Net)$0$0$917K$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$10K$0$0
Other Investing$0$0-$2M$3$0
Investing Cash Flow-$100K$0-$1M$0$0
— Financing Activities —
Net Debt Issuance$2M$3M$3M$952K$250K
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0$23K$202K
Financing Cash Flow$3M$4M$3M$974K$452K
Net Change in Cash-$32K$16K$344K-$649K-$132
Cash End of Period$5K$21K$365K$8K$8K
Free Cash Flow-$3M-$4M-$1M-$2M-$452K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms